{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:16:07Z","timestamp":1785269767153,"version":"3.55.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012505","name":"Royal Perth Hospital Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158169","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T22:06:26Z","timestamp":1467237986000},"page":"e0158169","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors"],"prefix":"10.1371","volume":"11","author":[{"given":"Alison","family":"Castley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Guelfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"JD Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy","author":"M Younas","year":"2015","journal-title":"HIV Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","article-title":"Residual immune dysregulation syndrome in treated HIV infection","volume":"119","author":"MM Lederman","year":"2013","journal-title":"Adv Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"569819","DOI":"10.1155\/2014\/569819","article-title":"Monocytes as regulators of inflammation and HIV-related comorbidities during cART","volume":"2014","author":"JJ Anzinger","year":"2014","journal-title":"J Immunol Res"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/QAI.0000000000000559","article-title":"Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively","volume":"69","author":"TA Angelovich","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1182\/blood-2012-05-433946","article-title":"Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome","volume":"120","author":"NT Funderburg","year":"2012","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"NG Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e115226","DOI":"10.1371\/journal.pone.0115226","article-title":"Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?","volume":"9","author":"A Castley","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"NI Wada","year":"2015","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2334-14-122","article-title":"Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study","volume":"14","author":"S Hattab","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/ATVBAHA.112.300421","article-title":"Soluble CD14: Genomewide association analysis and relationship to cardiovascular risk and mortality in older adults","volume":"33","author":"AP Reiner","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref12","article-title":"Determinants of residual viraemia during combination HIV treatment: impacts of baseline HIV RNA levels and treatment choice","author":"E McKinnon","year":"2015","journal-title":"HIV Medicine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/cid\/cit008","article-title":"Editorial commentary: can we break the habit of routine CD4 monitoring in HIV care?","volume":"56","author":"PE Sax","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"S Subramanian","year":"2012","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","article-title":"Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"68","author":"NT Funderburg","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref16","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"M Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/icb.2010.158","article-title":"CXCR3 ligands: redundant, collaborative and antagonistic functions","volume":"89","author":"JR Groom","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/01.aids.0000432455.06476.bc","article-title":"HIV-1 infection induces strong production of IP-10 through TLR7\/9-dependent pathways","volume":"27","author":"RP Simmons","year":"2013","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1189\/jlb.3A0414-232RR","article-title":"High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART","volume":"96","author":"LA Ramirez","year":"2014","journal-title":"J Leukoc Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e46143","DOI":"10.1371\/journal.pone.0046143","article-title":"Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection","volume":"7","author":"AS Liovat","year":"2012","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0000000000000174","article-title":"Elevated IP10 levels are associated with immune activation and low CD4\u207a T-cell counts in HIV controller patients","volume":"28","author":"N Noel","year":"2014","journal-title":"AIDS"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/infdis\/jiu621","article-title":"Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples","volume":"211","author":"EM Kahle","year":"2015","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/jiu594","article-title":"Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection","volume":"211","author":"RA McKibben","year":"2015","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"TH Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"KV Fitch","year":"2013","journal-title":"J Infect Dis"},{"key":"ref26","first-page":"9394","article-title":"Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease","volume":"8","author":"A Ilter","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.05.004","article-title":"The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis","volume":"184","author":"LP Aristoteli","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/eurheartj\/ehr123","article-title":"In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis","volume":"33","author":"JA Moreno","year":"2012","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/oby.20376","article-title":"The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss","volume":"21","author":"K Fjeldborg","year":"2013","journal-title":"Obesity"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1530\/JME-14-0089","article-title":"Regulation of CD163 mRNA and soluble CD163 protein in human adipose tissue in vitro","volume":"53","author":"K Fjeldborg","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1074\/jbc.M113.520213","article-title":"Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-\u03b1 in macrophages","volume":"289","author":"A Etzerodt","year":"2014","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0000000000000566","article-title":"Oxidized LDL levels are increased in HIV infection and may drive monocyte activation","volume":"69","author":"DA Zidar","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1310\/7381-M1YD-RTV5-4RYT","article-title":"Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy","volume":"7","author":"M Duong","year":"2006","journal-title":"HIV Clin Trials"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0b013e3182745ab0","article-title":"Low-level HIV viremia is associated with microbial translocation and inflammation","volume":"62","author":"S Reus","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-3083.2008.02184.x","article-title":"Residual viraemia in HIV-1-infected patients with plasma viral load <or = 20 copies\/ml is associated with increased blood levels of soluble immune activation markers","volume":"68","author":"SR Ostrowski","year":"2008","journal-title":"Scand J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/JVI.00284-11","article-title":"Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells","volume":"85","author":"JA Anderson","year":"2011","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/infdis\/jir208","article-title":"Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy","volume":"204","author":"TW Chun","year":"2011","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"11529","DOI":"10.1128\/JVI.01712-14","article-title":"Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism","volume":"88","author":"C Arenaccio","year":"2014","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/18715281113126660060","article-title":"Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases","volume":"12","author":"C Buechler","year":"2013","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/civ327","article-title":"Changes in inflammation and immune activation with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy: ACTG 5260s","volume":"61","author":"T Kelesidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/infdis\/jit025","article-title":"Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14","volume":"207","author":"G M\u00e9ndez-Lagares","year":"2013","journal-title":"J Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/QAI.0000000000000759","article-title":"Elevated soluble CD14 and lower D-Dimer are associated with cigarette smoking and heavy episodic alcohol use in persons living with HIV","volume":"70","author":"PA Cioe","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/jiv004","article-title":"Differential reduction in monocyte activation and vascular inflammation with integrase inhibitor-based initial antiretroviral therapy among HIV-Infected individuals","volume":"212","author":"CO Hileman","year":"2015","journal-title":"J Infect Dis"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/hiv.12128","article-title":"Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial","volume":"15","author":"JE Lake","year":"2014","journal-title":"HIV Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/infdis\/jir559","article-title":"Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial","volume":"204","author":"H Byakwaga","year":"2011","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ebiom.2015.07.025","article-title":"During stably suppressive antiretroviral therapy integrated HIV-1 DNA load in peripheral blood is associated with the frequency of CD8 cells expressing HLA-DR\/DP\/DQ","volume":"2","author":"A Ruggiero","year":"2015","journal-title":"EBioMedicine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","article-title":"Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America","volume":"29","author":"M Helleberg","year":"2015","journal-title":"AIDS"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1468-1293.2010.00901.x","article-title":"Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study","volume":"12","author":"K Petoumenos","year":"2011","journal-title":"HIV Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:27:37Z","timestamp":1589675257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158169"}},"subtitle":[],"editor":[{"given":"Cristian","family":"Apetrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158169","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]}}}